CG Structure · 2024
In this section17 topics
- Board Composition8 items
- Board of Directors1 item
- Board Meetings & Remuneration5 items
- Balance of Power Between the Board and Management3 items
- Board Roles, Duties and Charter2 items
- Other Board Governance Matters1 item
- Audit Committee5 items
- Executive Committee5 items
- Executives1 item
- Executive Remuneration3 items
- Remuneration Policy2 items
- Employees2 items
- Provident Fund2 items
- Auditors and Audit Fees4 items
- Company Secretary and Other Assigned Persons3 items
- Investor Relations Contact2 items
- Representatives in Thailand (Foreign Companies)1 item
Board Composition
Total Number of Directors
11
Male Directors
10
Female Directors
1
Independent Directors
4
Non-executive Directors
9
Non-executive Directors Who Are Not Independent
5
Executive Directors
2
Total Board Meetings Held
5
Board of Directors
Directors
| Title | First Name | Last Name | Gender | Year of Birth | Nationality | Resident in Thailand? | Position | Executive or Non-executive | Independent Director? | Director Type | Appointment Date | Authorised to Sign? | Related to Another Director or Executive? | Any Legal Violation in the Past 5 Years? | Highest Education | Field of Study | Skills & Expertise | Director Training | Attended Director Training? | Director Accreditation Program (DAP)? | Director Certification Program (DCP)? | Board Meetings Held | Board Meetings Attended | AGMs Held | AGMs Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration | Shares Held | Shareholding (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mr. | THOSAPORN | SIRISUMPHAND | M | 1,960 | 643 · Description: Thailand | Y | Chairman of the board | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2022-01-28T00:00 | N | N | N | Doctoral degree | Political Science | 1683 · Description: Business Administration · 158 · Description: Corporate Management · 3173 · Description: Public Administration | N | N | Y | 5 | 5 | 1 | 1 | 0 | 600,000 | 600,000 | 0 | 0 | 300,000 | 0.05 | |
| Mr. | PREECHA | LAOHAPONGCHANA | M | 1,954 | 643 · Description: Thailand | Y | Director | Non-executive | N | Existing director | 2017-09-11T00:00 | Y | N | N | Master's degree | Law | 1683 · Description: Business Administration · 141 · Description: Law · 133 · Description: Commerce | N | Y | N | 5 | 5 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | 73,638,000 | 12.27 | |
| Mr. | GOANPOT | ASVINVICHIT | M | 1,956 | 643 · Description: Thailand | Y | Director | Non-executive | N | Existing director | 2020-06-25T00:00 | Y | N | N | Master's degree | Business Administration | 1683 · Description: Business Administration · 112 · Description: Economics · 118 · Description: Banking | N | Y | Y | 5 | 5 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | 100,000 | 0.02 | |
| Mr. | NING | LI | M | 1,981 | 479 · Description: China | N | Director | Non-executive | N | Continuing director (Full term of directorship and being re-appointed as a director) | 2020-06-25T00:00 | Y | N | N | Doctoral degree | Science | 134 · Description: Health Care Services | N | Y | N | 5 | 1 | 1 | 0 | 0 | 480,000 | 480,000 | 0 | 0 | |||
| Mr. | SUJIE | CAO | M | 1,986 | 479 · Description: China | N | Director | Non-executive | N | Continuing director (Full term of directorship and being re-appointed as a director) | 2020-06-25T00:00 | Y | N | N | Bachelor's degree | Science | 134 · Description: Health Care Services | N | Y | N | 5 | 5 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | 2,450,000 | 0.41 | |
| Mr. | ZONGZE | WU | M | 1,983 | 479 · Description: China | N | Director | Non-executive | N | Existing director | 2022-01-28T00:00 | Y | N | N | Doctoral degree | Science | 134 · Description: Health Care Services | N | Y | N | 5 | 2 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | |||
| Ms. | SAOWALAK | DANSAKUL | F | 1,979 | 643 · Description: Thailand | Y | Director | Executive | Existing director | 2022-01-28T00:00 | Y | N | N | Doctoral degree | Science | 134 · Description: Health Care Services · 113 · Description: Agribusiness | 1731 · Year: 2024 · Description: Director Certification Program (DCP) · 1738 · Year: 2024 · Description: Subsidiary Governance Program (SGP) · 2024 · Description: Arbitration Procedure Training Program · 2024 · Description: Cybersecurity Leadership Certificate Program for Business · 2024 · Description: Medical Leadership Certificate, Class 1 | Y | Y | Y | 5 | 5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2,000,000 | 0.33 | |
| Mr. | XIAOHAN | WANG | M | 1,990 | 479 · Description: China | N | Director | Executive | Existing director | 2022-01-28T00:00 | Y | N | N | Bachelor's degree | Science | 1683 · Description: Business Administration · 134 · Description: Health Care Services | N | Y | N | 5 | 5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 2,250,000 | 0.38 | ||
| Mr. | VICHATE | TANTIWANICH | M | 1,961 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2022-01-28T00:00 | N | N | N | Master's degree | Business Administration | 165 · Description: Risk Management · 166 · Description: Audit · 1683 · Description: Business Administration · 112 · Description: Economics · 150 · Description: IT Management | N | N | Y | 5 | 5 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | 52,600 | 0.01 | |
| Mr. | VICHYA | KREANGAM | M | 1,981 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Continuing director (Full term of directorship and being re-appointed as a director) | 2022-01-28T00:00 | N | N | N | Doctoral degree | Law | 141 · Description: Law | N | Y | N | 5 | 5 | 1 | 1 | 0 | 480,000 | 480,000 | 0 | 0 | |||
| Mr. | JEDSADA | CHOKDAMRONGSUK | M | 1,958 | 643 · Description: Thailand | Y | Director | Non-executive | Y | Existing director | 2023-06-22T00:00 | N | N | N | Bachelor's degree | Medicine | 134 · Description: Health Care Services | N | N | Y | 5 | 5 | 1 | 0 | 0 | 480,000 | 480,000 | 0 | 0 |
Board Meetings & Remuneration
Date of the Annual General Meeting
2024-02-29T00:00
Was an Extraordinary General Meeting Held?
No
Board Meeting Allowance (Baht)
0.0
Other Board Remuneration (Baht)
4440000.0
Total Board Remuneration (Baht)
4440000.0
Balance of Power Between the Board and Management
Are There Measures Balancing the Board's and Management's Power?
Yes
Measures Balancing the Board's and Management's Power
The Company has appointed four independent directors, accounting for 36.36% of the total 11 directors, and nine non-executive directors, representing 81.82% of the total board members. This composition ensures a balance of power between executive directors and management. Regarding the board meeting agenda setting, an independent director or the chairman, who is also an independent director, must be involved in the agenda-setting process. If the chairman is unable to attend or participate in setting the agenda, the chairman of the audit committee or an appointed representative acting as the meeting chairman will be responsible for determining the agenda. Additionally, those involved in the agenda-setting process must not be executive directors.
Methods Used to Balance Power
| Method |
|---|
| Appointment of an independent director Participate in determining the meeting agenda for the committee |
Board Roles, Duties and Charter
Does the Company Have a Board Charter?
Yes
Content of the Board Charter
Scope of Authority, Duties, and Responsibilities of the Board of Directors are as follows;
1. Define the objectives, key business goals, vision, mission, policies, strategies, business plans, organizational structure, approval authority, and budget of the Company. Supervise the allocation of key resources and review, examine, and approve the Company's policies, strategies, business plans, and operational direction, including those of its subsidiaries, as proposed by the management.
2. Monitor and supervise the Company's performance, management, and operations, ensuring alignment with the Company’s objectives, vision, mission, strategies, business plans, and budget to maximize value for the Company and its shareholders effectively and efficiently.
3. Oversee the Company’s management and operations to ensure compliance with its policies, corporate governance principles, securities laws, and related regulations issued by the Securities and Exchange Commission (SEC) and the Stock Exchange of Thailand (SET), including related-party transactions and significant asset acquisitions or disposals, provided that they do not conflict with other laws.
4. Establish a comprehensive risk management policy covering the entire organization and oversee the implementation of appropriate risk management systems and control measures to mitigate business risks effectively.
5. Ensure the implementation of an appropriate and effective accounting system, including an internal control system and internal audit process, and conduct regular assessments of the adequacy of the Company's internal control system.
6. Define the management structure, including the authority to appoint subcommittees, the Chief Executive Officer (CEO), and other committees as deemed appropriate. The delegation of authority must not allow subcommittees, the CEO, or other committees to approve transactions that may involve conflicts of interest unless they comply with the policies and criteria previously approved by the Board.
7. Establish corporate governance policies in written form, ensure their effective implementation, and promote ethical business practices that respect the rights of shareholders and stakeholders, contributing positively to society and the environment while maintaining adaptability to changing business conditions.
8. Manage and address conflicts of interest among stakeholders, including preventing the misuse of the Company's assets, information, and opportunities, as well as improper transactions with related parties. Any director with a personal interest in a transaction involving the Company or a change in shareholding proportion must immediately notify the Company.
9. The Board may delegate authority to one or more directors or other individuals to act on its behalf under the Board’s supervision. The Board may revoke, withdraw, modify, or amend such delegation of authority as necessary. However, such delegation must not permit decision-making or approvals of transactions where the delegate has a conflict of interest, personal gain, or other conflicting interests with the Company, as defined by the Capital Market Supervisory Board and/or SET regulations, unless the transactions comply with the policies and guidelines previously approved by the Board.
Other Board Governance Matters
Board Governance Practices
| Practice | Yes / No |
|---|---|
| The chairman of the board and the highest-ranking executive are from the same person | N |
| The chairman of the board is an independent director | Y |
| The chairman of the board and the highest-ranking executive are from the same family | N |
| Chairman is a member of the executive board or taskforce | N |
| The company appoints at least one independent director to determine the agenda of the board of directors’ meeting | Y |
Audit Committee
Audit Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
1. Review the Company's financial reports to ensure accuracy and adequate disclosure.
2. Review the Company's internal control system and internal audit system for appropriateness and effectiveness, as well as assess the independence of the internal audit function. This includes approving the appointment, transfer, dismissal, and remuneration of the head of internal audit or any other department responsible for internal audit.
3. Review the Company's risk management policies and implementation to ensure compliance with established guidelines.
4. Ensure the Company's compliance with securities and exchange laws, stock exchange regulations, and other applicable business laws.
5. Evaluate, select, and propose the appointment of an independent auditor and determine their remuneration. Additionally, hold at least one meeting per year with the external auditor without management participation.
6. Review related-party transactions and potential conflict of interest transactions to ensure compliance with securities laws and stock exchange regulations, ensuring that such transactions are reasonable and in the best interest of the Company.
7. Prepare and disclose an Audit Committee Report in the Annual Report, signed by the Chairman of the Audit Committee, including at least the following:
7.1) Opinion on the accuracy, completeness, and reliability of the Company's financial reports.
7.2) Opinion on the adequacy of the internal control system.
7.3) Opinion on compliance with securities laws, stock exchange regulations, and other applicable business laws.
7.4) Opinion on the appropriateness of the external auditor.
7.5) Opinion on transactions that may involve conflicts of interest.
7.6) Number of Audit Committee meetings and attendance records of each committee member.
7.7) Overall observations and recommendations based on duties performed under the Audit Committee Charter.
8. Report any other matters that shareholders and investors should be aware of, within the scope of duties assigned by the Board of Directors, including reviewing and approving the Company's internal audit plan and evaluating the performance of the internal control auditor.
9. The Audit Committee has the authority to seek independent professional opinions when necessary, at the Company's expense.
10. Ensure the Company complies with corporate governance, social responsibility, and anti-corruption policies, including handling fraud and corruption complaints from internal personnel, conducting investigations, and submitting cases to the Board of Directors for disciplinary action and resolution.
11. If the Audit Committee identifies or suspects any of the following issues that may significantly impact the Company's financial position and performance, it must report to the Board of Directors for timely corrective action:
11.1) Transactions that may involve conflicts of interest.
11.2) Fraud, irregularities, or significant deficiencies in internal control systems.
11.3) Violations of securities laws, stock exchange regulations, or other applicable business laws.
12. Perform any other duties assigned by the Board of Directors. | 3091 · Description: Audit of financial statements and internal controls · 3092 · Description: Risk management |
Audit Committee Members
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Has Accounting or Financial Expertise? | Skills & Expertise | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mr. | VICHATE | TANTIWANICH | Chairman of the audit committee | M | 1,961 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Master's degree | Business Administration | Y | 165 · Description: Risk Management · 166 · Description: Audit · 1683 · Description: Business Administration · 112 · Description: Economics · 150 · Description: IT Management | 4 | 4 | 80,000 | 0 | 80,000 | 0 | 0 |
| Mr. | VICHYA | KREANGAM | Audit committee | M | 1,981 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Doctoral degree | Law | N | 141 · Description: Law | 4 | 4 | 60,000 | 0 | 60,000 | 0 | 0 |
| Mr. | JEDSADA | CHOKDAMRONGSUK | Audit committee | M | 1,958 | 643 · Description: Thailand | Y | 2023-06-22T00:00 | Bachelor's degree | Medicine | N | 134 · Description: Health Care Services | 4 | 4 | 60,000 | 0 | 60,000 | 0 | 0 |
Audit Committee — Meeting Allowance (Baht)
200000.0
Audit Committee — Other Remuneration (Baht)
0.0
Audit Committee — Total Remuneration (Baht)
200000.0
Executive Committee
Executive Committee Charter
| Roles, Duties and Responsibilities | Type of Subcommittee |
|---|---|
1. Conduct and manage the Company’s operations in accordance with its objectives, articles of association, policies, regulations, resolutions of the Board of Directors and/or shareholder meetings, within the framework of applicable laws.
2. Review and evaluate management proposals regarding organizational structure, vision, mission, goals, policies, business strategies, operational plans, investment expansion, financial planning, annual report, budget allocation, human resource management, and IT investments, before submitting them for Board approval.
3. Appoint working committees for specific tasks, define their roles, responsibilities, and authority, and oversee their performance to ensure alignment with the Company’s policies and goals.
4. Provide guidance, advice, and policy direction to the Chief Executive Officer (CEO) and special task forces.
5. Monitor the performance of the Company and its subsidiaries to ensure operations are aligned with approved policies and objectives, maintaining quality and efficiency.
6. Review and approve the annual budget allocation proposed by management before submission to the Board of Directors for approval.
7. Approve financial expenditures for regular business transactions, provided they do not exceed the budget approved by the Board.
8. Assess feasibility and approve participation in new projects, bids, and contracts, ensuring compliance with legal and stock exchange regulations.
9. Approve significant capital expenditures as outlined in the Company’s annual budget, as delegated by the Board.
10. Authorize loan transactions, banking and financial operations, including account openings, loan applications, intra-group financing, and credit facilities, within the approved limits. Any exceeding amounts must be submitted to the Board for review in the next meeting. If assets are used as collateral, prior Board approval is required.
11. Monitor the Company’s financial performance and propose dividend payments to the Board for approval.
12. Establish the Company’s organizational structure, management authority, hiring, promotion, transfer, termination, and compensation policies for executives at the director level or equivalent, excluding the CEO.
13. Delegate authority to individuals or committees to conduct Company operations, ensuring oversight and compliance with governance principles. This authority can be revoked, amended, or modified as deemed necessary.
14. Appoint advisory committees and consultants, including determining remuneration, allowances, benefits, and other related expenses.
15. Appoint executive positions within the Company, except for the CEO, which requires Board approval.
16. Convene Executive Committee meetings and set meeting regulations as deemed necessary.
17. Approve operational authority for executives in line with Company rules and regulations.
18. Ensure the Company maintains an effective internal control system, coordinating with the Audit Committee.
19. Nominate qualified candidates for director and executive positions in subsidiaries and affiliates, ensuring governance compliance before seeking Board approval.
20. Perform any other duties assigned by the Board of Directors.
Authority Limitations
The delegation of authority to the Executive Committee shall not include approval for transactions where members have conflicts of interest, personal gains, or related party transactions, as defined by the Securities and Exchange Commission (SEC), Stock Exchange of Thailand (SET), and other relevant regulators. Such matters must be presented to the Board or shareholders for approval, except for transactions conducted under normal business operations and standard commercial terms as defined by the SEC, SET, or other relevant authorities. | 3093 · Description: Director and executive nomination · 3094 · Description: Remuneration · 3096 · Description: Sustainability development |
Executive Committee Members
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Meetings Held | Meetings Attended | Meeting Allowance (Baht) | Other Remuneration (Baht) | Total Remuneration (Baht) | Remuneration from Subsidiaries (Baht) | Non-monetary Remuneration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mr. | GOANPOT | ASVINVICHIT | Chairman of the executive committee | M | 1,956 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Master's degree | Business Administration | 4 | 4 | 80,000 | 0 | 80,000 | 0 | 0 |
| Mr. | PREECHA | LAOHAPONGCHANA | Member of the executive committee | M | 1,954 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Master's degree | Law | 4 | 4 | 60,000 | 0 | 60,000 | 0 | 0 |
| Mr. | SUJIE | CAO | Member of the executive committee | M | 1,986 | 479 · Description: China | N | 2022-01-28T00:00 | Bachelor's degree | Science | 4 | 4 | 60,000 | 0 | 60,000 | 0 | 0 |
| Ms. | SAOWALAK | DANSAKUL | Member of the executive committee | F | 1,979 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Doctoral degree | Science | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
| Mr. | XIAOHAN | WANG | Member of the executive committee | M | 1,990 | 479 · Description: China | N | 2022-01-28T00:00 | Bachelor's degree | Science | 4 | 4 | 0 | 0 | 0 | 0 | 0 |
Executive Committee — Meeting Allowance (Baht)
200000.0
Executive Committee — Other Remuneration (Baht)
0.0
Executive Committee — Total Remuneration (Baht)
200000.0
Executives
Executives
| Title | First Name | Last Name | Position | Gender | Year of Birth | Nationality | Resident in Thailand? | Appointment Date | Highest Education | Field of Study | Field of Study — Please Specify | Skills & Expertise | Is the Highest-ranking Executive? | Is the Highest-ranking Accounting or Finance Officer? | Directly Responsible for Accounting? | Appointed After the End of the Fiscal Year? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ms. | SAOWALAK | DANSAKUL | CHIEF EXECUTIVE OFFICER | F | 1,979 | 643 · Description: Thailand | Y | 2022-01-28T00:00 | Doctoral degree | Science | 134 · Description: Health Care Services · 113 · Description: Agribusiness | Y | N | N | N | |
| Mr. | XIAOHAN | WANG | Deputy Chief Executive Officer | M | 1,990 | 479 · Description: China | N | 2019-10-01T00:00 | Bachelor's degree | Science | 1683 · Description: Business Administration · 134 · Description: Health Care Services | N | N | N | N | |
| Mr. | Kittikun | Rodrangnok | Chief Financial Officer | M | 1,990 | 643 · Description: Thailand | Y | 2021-09-23T00:00 | Bachelor's degree | Accounting | 143 · Description: Accounting | N | Y | Y | N | |
| Mr. | Porntep | Tanyut | Chief Operating Officer | M | 1,986 | 643 · Description: Thailand | Y | 2024-01-03T00:00 | Master's degree | other | Department of Immunology | 134 · Description: Health Care Services | N | N | N | N |
| Mr. | Siriyod | Denmongkholchai | Laboratory Director | M | 1,989 | 643 · Description: Thailand | Y | 2023-12-21T00:00 | Doctoral degree | other | Department of Medical Microbiology (Interdisciplinary) | 134 · Description: Health Care Services | N | N | N | N |
Executive Remuneration
Monetary Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total remuneration of executive directors and executives (baht) | 9,432,474 | 10,875,574.46 | 8,751,665.17 |
| Total remuneration of executive directors (baht) | |||
| Total remuneration of executives (baht) |
Other Remuneration
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Company’s contribution to provident fund for executive directors and executives (Baht) | 395,090 | 349,000 | 124,000 |
| Employee Stock Ownership Plan (ESOP) | 0 | 0 | 0 |
| Employee Joint Investment Program (EJIP) | 0 | 0 | 0 |
Remuneration or Benefits Payable to Executives
| Metric | Amount (Baht) |
|---|---|
| Outstanding remuneration or benefits of executive directors and executives in the past year (baht) | 432,000 |
| Estimated remuneration of executive directors and executives in the current year (baht) |
Remuneration Policy
Executive Remuneration Policy
The Company recognizes the significance of the roles, duties, and responsibilities of the Board of Directors, Audit Committee, Executive Committee, and senior management, as they are key figures in driving the business towards its objectives, goals, and sustainable growth. Therefore, the Company carefully considers the structure and remuneration levels for directors to ensure they are appropriate to their responsibilities and serve as an incentive for the Board to lead the organization toward both short-term and long-term success. The remuneration of directors must align with the Company’s long-term strategies and goals, their experience, duties, scope of roles and responsibilities, and the expected contributions of each director. The remuneration structure is designed to be comparable to industry standards while being subject to shareholder approval, ensuring that compensation remains reasonable and not excessive. The following criteria are used to determine director and executive compensation:
1. Evaluate and establish appropriate compensation structures and criteria for the remuneration of the Board of Directors, Chief Executive Officer (CEO), and Deputy Chief Executive Officer (Deputy CEO) to ensure fairness and suitability.
2. Determine performance evaluation criteria for the CEO and Deputy CEO, which will be submitted to the Board of Directors for approval.
3. Set annual or quarterly remuneration for directors, the CEO, and the Deputy CEO, considering the CEO’s performance evaluation results, and include this matter in the Board meeting agenda for approval.
4. Review conditions and details of new securities offerings or stock options for directors and employees, if applicable.
5. Ensure director compensation is competitive within the industry, reflecting their experience, responsibilities, and expected contributions. Directors with additional roles, such as serving on subcommittees, should receive appropriate additional compensation.
6. Ensure compensation for the CEO, Deputy CEO, and senior executives follows the policies set by the Board within the approved framework from the shareholders' meeting. The salary, bonuses, and long-term incentives should align with the Company’s performance and the individual performance of each executive, ensuring the best interests of the Company.
Was an Opinion Obtained from the Board and the Remuneration Committee?
No
Employees
Any Significant Change in Headcount in the Past 3 Years?
Yes
Significant Changes in Headcount
Currently, the labor market is highly competitive, leading companies to attract skilled personnel with more appealing offers, including compensation, benefits, and career advancement opportunities. These factors are the primary reasons why companies are facing increased employee turnover rates, which significantly impacts the number of employees.
Provident Fund
Does the Company Have a Provident Fund?
Yes
Provident Fund Policy
The company has established a provident fund as a guarantee of security and to motivate employees, managed by SCB Asset Management Company Limited under the name "SCB Provident Fund Master Fund," which is registered with the Securities and Exchange Commission (SEC). The company selects the fund based on its past performance and the fees associated with fund management.
Auditors and Audit Fees
How Audit Fees Are Reported
SEPERATE
Company Auditor and Fees
| Audit Firm | Sub-district | District | Province | Postcode | Auditors | Audit Fee (Baht) | Any Non-audit Fee? |
|---|---|---|---|---|---|---|---|
| DR. VIRACH AND ASSOCIATES COMPANY LIMITED | WAT THA PHRA | BANGKOK YAI | Bangkok | 10600 | virach_asso@vaaudit.com · Title: 260 · Regis no: 3196 · Last name: AUNPITIPONGSA · First name: CHAIYAKORN | 1,610,000 | N |
How Subsidiary Audit Information Is Reported
AUDITOR_AND_FEE
Subsidiary Auditors and Fees
| Audit Firm | Sub-district | District | Province | Postcode | Auditors | Audit Fee (Baht) | Any Non-audit Fee? |
|---|---|---|---|---|---|---|---|
| DR. VIRACH AND ASSOCIATES COMPANY LIMITED | WAT THA PHRA | BANGKOK YAI | Bangkok | 10600 | virach_asso@vaaudit.com · Title: 260 · Regis no: 3196 · Last name: AUNPITIPONGSA · First name: CHAIYAKORN | 45,000 | N |
Company Secretary and Other Assigned Persons
Company Secretary
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Ms. | Nuttinee | Kittisorayut | nuttinee@bangkokgenomics.com | 062-1588783 |
Chief Accountant
| Title | First Name | Last Name | |
|---|---|---|---|
| Mr. | Kittikun | Rodrangnok | kittikun@bangkokgenomics.com |
Head of Internal Audit
| Title | First Name | Last Name | |
|---|---|---|---|
| Ms. | Wanvimol | Jongsureeyapas | wanvimol.jo@plgroup.co.th |
Investor Relations Contact
Does the Company Have an Investor Relations Contact?
Yes
Investor Relations Contacts
| Title | First Name | Last Name | Telephone | |
|---|---|---|---|---|
| Mr. | Kittikun | Rodrangnok | kittikun@bangkokgenomics.com | 063-0211580 |
Representatives in Thailand (Foreign Companies)
Does the Company Have Representatives in Thailand?
No
